Clinical Significance of Acute Kidney Injury in Lung Cancer Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Acute kidney injury (AKI) in cancer patients is associated with increased morbidity and mortality. The incidence of AKI in lung cancer seems to be relatively higher compared with other solid organ malignancies, although its impact on patient outcomes remains unclear. Materials and Methods The patients newly diagnosed with lung cancer from 2004 to 2013 were enrolled in this retrospective cohort study. The patients were categorized according to the presence and severity of AKI. We compared all-cause mortality and long-term renal outcome according to AKI stage. Results A total of 3,202 patients were included in the final analysis. AKI occurred in 1,783 (55.7%) patients during the follow-up period, with the majority having mild AKI stage 1 (75.8%). During the follow-up of 2.6±2.2 years, total 1,251 patients (53.7%) were died and 5-year survival rate was 46.9%. We found that both AKI development and severity were independent risk factors for all-cause mortality in lung cancer patients, even after adjustment for lung cancer-specific variables including the stage or pathological type. In addition, patients suffered from more severe AKI tend to encounter de novo chronic kidney disease development, worsening kidney function, and end-stage kidney disease progression. Conclusion In this study, more than half of the lung cancer patients experienced AKI during their diagnosis and treatment period. Moreover, AKI occurrence and more advanced AKI were associated with a higher mortality risk and adverse kidney outcomes.
Abstract
Purpose Acute kidney injury (AKI) in cancer patients is associated with increased morbidity and mortality. The incidence of AKI in lung cancer seems to be relatively higher compared with other solid organ malignancies, although its impact on patient outcomes remains unclear. Materials and Methods The patients newly diagnosed with lung cancer from 2004 to 2013 were enrolled in this retrospective cohort study. The patients were categorized according to the presence and severity of AKI. We compared all-cause mortality and long-term renal outcome according to AKI stage. Results A total of 3,202 patients were included in the final analysis. AKI occurred in 1,783 (55.7%) patients during the follow-up period, with the majority having mild AKI stage 1 (75.8%). During the follow-up of 2.6±2.2 years, total 1,251 patients (53.7%) were died and 5-year survival rate was 46.9%. We found that both AKI development and severity were independent risk factors for all-cause mortality in lung cancer patients, even after adjustment for lung cancer-specific variables including the stage or pathological type. In addition, patients suffered from more severe AKI tend to encounter de novo chronic kidney disease development, worsening kidney function, and end-stage kidney disease progression. Conclusion In this study, more than half of the lung cancer patients experienced AKI during their diagnosis and treatment period. Moreover, AKI occurrence and more advanced AKI were associated with a higher mortality risk and adverse kidney outcomes.
참고문헌 (35)
- Berns JS, "Onco-nephrology : what the nephrologist needs to know about cancer and the kidney", Clin J Am Soc Nephrol, 7, pp.1691~ (2012)
- Rosner MH, "Acute kidney injury in patients with cancer", N Engl J Med, 376, pp.1770~1781 (2017)
- Janus N, "Cancer and renal insufficiency results of the BIRMA study", Br J Cancer, 103, pp.1815~1821 (2010)
- Christiansen CF, "Incidence of acute kidney injury in cancer patients : a Danish population-based cohort study", Eur J Intern Med, 22, pp.399~406 (2011)
- Lam AQ, "Onco-nephrology : AKI in the cancer patient", Clin J Am Soc Nephrol, 7, pp.1692~1700 (2012)
- Kogon A, "Acute kidney injury in hematopoietic cell transplantation", Semin Nephrol, 30, pp.615~626 (2010)
- Rosolem MM, "Critically ill patients with cancer and sepsis : clinical course and prognostic factors", J Crit Care, 27, pp.301~307 (2012)
- Canet E, "Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies : impact on remission and survival", PLoS One, 8, pp.e55870~ (2013)
- Kitchlu A, "Acute kidney injury in patients receiving systemic treatment for cancer : a population-based cohort study", J Natl Cancer Inst, 111, pp.727~736 (2019)
- Park SE, "Incidence, risk factors, and clinical outcomes of acute kidney injury caused by palliative chemotherapy in lung cancer", J Cancer, 10, pp.5332~5338 (2019)
- Cardinale D, "Acute kidney injury after lung cancer surgery : Incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide", Lung Cancer, 123, pp.155~159 (2018)
- Fernandez FG, "Differential effects of operative complications on survival after surgery for primary lung cancer", J Thorac Cardiovasc Surg, 155, pp.1254~1264 (2018)
- Park N, "Predicting acute kidney injury in cancer patients using heterogeneous and irregular data", PLoS One, 13, pp.e0199839~ (2018)
- Kang E, "Acute kidney injury predicts all-cause mortality in patients with cancer", Cancer Med, 8, pp.2740~2750 (2019)
- Park PG, "Acute kidney injury in pediatric cancer patients", J Pediatr, 208, pp.243~250 (2019)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Young JL Jr, "SEER summary staging manual 2000" (2001), National Cancer Institute
- Santos ML, "Nephrotoxicity in cancer treatment : an overview", World J Clin Oncol, 11, pp.190~204 (2020)
- Kunitoh H, "Top 10 reasons why you must learn onco-nephrology", Jpn J Clin Oncol, 46, pp.2~3 (2016)
- Ettinger DS, "NCCN guidelines for non-small cell lung cancer" (2020), National Comprehensive Cancer Network
- Kidney Disease : Improving Global Outcomes(KDIGO)Acute Kidney Injury Work Group, "KDIGO clinical practice guideline for acute kidney injury", Kidney Int Suppl, 2, pp.1~138 (2012)
- Samuels J, "Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer", Support Care Cancer, 19, pp.1527~1532 (2011)
- Aygencel G, "Prognostic factors in critically ill cancer patients admitted to the intensive care unit", J Crit Care, 29, pp.618~626 (2014)
- Bernhardt EB, "Small cell lung cancer", Cancer Treat Res, 170, pp.301~322 (2016)
- "CKD as a complication of cancer" (2016)[URL]
- 박세훈, "Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group", Kidney Research and Clinical Practice, 38(1), pp.60~70 (2019), 대한신장학회[DOI]
- Fossa SD, "Long term physical sequelae after adult-onset cancer", J Cancer Surviv, 2, pp.3~11 (2008)
- Kim M, "Increased prevalence of metabolic syndrome in adult cancer survivors : Asian first report in community setting", Cancer Epidemiol, 58, pp.130~136 (2019)
- Vigneri P, "Diabetes and cancer", Endocr Relat Cancer, 16, pp.1103~1123 (2009)
- Rizzoli R, "Cancer-associated bone disease", Osteoporos Int, 24, pp.2929~2953 (2013)
- Porta C, "Renal effects of targeted anticancer therapies", Nat Rev Nephrol, 11, pp.354~370 (2015)
- Lamb EJ, "Estimating kidney function in adults using formulae", Ann Clin Biochem, 42(Pt 5), pp.321~345 (2005)
- Ma YC, "Improved GFR estimation by combined creatinine and cystatin C measurements", Kidney Int, 72, pp.1535~1542 (2007)
- Darmon M, "Clinical review : specific aspects of acute renal failure in cancer patients", Crit Care, 10, pp.211~ (2006)
- Shingarev R, "Kidney complications of immune checkpoint inhibitors : a review", Am J Kidney Dis, 74, pp.529~537 (2019)